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Abstract: Skin cancer incidence has increased exponentially over the last 
three decades. In 2008 skin cancer caused 2280 deaths in the UK, with 2067 
due to malignant melanoma. Early diagnosis can prevent mortality, 
however, conventional treatment requires multiple procedures and 
increasing treatment times. Second harmonic generation (SHG) imaging 
could offer diagnosis and demarcation of melanoma borders non-invasively 
at presentation thereby short-cutting the excision biopsy stage. To test the 
efficacy and accuracy of SHG imaging of collagen in skin and to delineate 
the borders of skin cancers, unstained human melanoma biopsy sections 
were imaged using SHG microscopy. Comparisons with sister sections, 
stained with H&E or Melan-A were made for correlation of invasion 
borders. Fresh ex vivo normal human and rat skin was imaged through its 
whole thickness using SHG to demonstrate this technique is transferable to 
in vivo tissues. SHG imaging demonstrated detailed collagen distribution in 
normal skin, with total absence of SHG signal (fibrillar collagen) within the 
melanoma-invaded tissue. The presence or absence of signal changes 
dramatically at the borders of the melanoma, accurately demarcating the 
edges that strongly correlated with H&E and Melan-A defined borders 
(p<0.002). SHG imaging of ex vivo human and rat skin demonstrated 
collagen architecture could be imaged through the full thickness of the skin. 
We propose that SHG imaging could be used for diagnosis and accurate 
demarcation of melanoma borders on presentation and therefore potentially 
reduce mortality rates. 
© 2011 Optical Society of America 
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Skin cancer is one of the most common forms of cancer in the UK totaling around 84,500 
registered cases in 2007 with 10,672 case of these being malignant melanoma (MM) [1–5]. 
The total cost of skin cancer in the UK in 2002 was estimated to be in excess of £190 million 
[6]. In that year, 63% of the total costs of skin cancer were attributable to MM alone, 
amounting to 1770 cases [6] and the number continues to rise (1852 in 2006), resulting in a 
doubling of reported cases since the early 1970’s (Quinn et al., 2001). 
Globally, there were more than 161,000 reports of MM alone in 2002, with Australia/New 
Zealand having the highest incidence followed by Northern America, Northern Europe and 
Western Europe (67, 27.1, 18.5 and 17.6 cases/100,000, respectively) [7]. These numbers are 
predicted to continue rise over the next few decades. Although MM becomes more common 
with increasing age, these trends have changed more recently with an abnormally high 
incidence in the young; with MM becoming the most common form of cancer in people aged 
15-34, a 300% increase between 1975 and 2006 [1]. The greatest increase was found in the 
60-79 year old group, particularly in males, which has seen an increase of over 600% in the 
same period [1]. 
Early diagnosis and treatment can prevent death for the majority of these patients. The 
normal route for diagnosis is a Post-Hoc method that builds-in an inherent delay in the 
diagnostic procedure. This involves histological processing of the tissue followed by 
analysis/diagnosis by an expert pathologist to assess the severity of the MM and the margins 
of the invading cancer cells based on Breslow thickness measurements. This may result in the 
patient having to undergo two or more operations to surgically remove the entire tumour, if 
some of the affected tissue was not removed at the first biopsy stage. For irregular shaped 
cancers, simply applying Breslow depth measurements to calculate the margins of the cancer 
to excise the lesion is inadequate and results in further excision biopsies being necessary to 
remove all the diseased tissue. This delay can lead to the cancer metastasizing to other tissues 
and significantly worsen the prognosis for the patient. 
During their invasion of surrounding tissues, both Melanoma and Non-Melanoma Skin 
Cancer (NMSC) utilize the same biological events [8–13]. They are characterized by active 
invasion and destruction of surrounding connective tissue. Penetration of the cancer through 
the basement membrane (BM) is the initial step in the complex process of invasion and 
metastasis. This process when simplified consists of three distinct events: 1. attachment to the 
BM, via various cell surface receptors. 2. degradation of the BM and extracellular matrix by a 
series of matrix metalloproteinases (MMPs). 3. cancer cell locomotion into the surrounding 
tissue induced by chemotaxis. Therefore, a key features of all skin cancers is the degrading 
and remodeling of the extracellular matrix along the borders of the invading cancer, 
principally collagen type I, by matrix MMPs [8–13],  but little is known about the differential 
disruption of collagen density and morphology between MM and NMSC . We propose that 
this degradation of collagen along the borders of the invading cancer can be used to, a) 
accurately define the margins of the skin cancer, and b) aide in the diagnosis of a malignant 
condition. 
Confocal microscopy has been the subject of intensive investigation in the scientific 
community in recent years, not least in the field of cancer biology [14,15]. More recently, 
multiphoton fluorescence microscopy (MPFM) has been used for non-invasive imaging of the 
epidermis in a number of studies [16,17]. Since MPFM is a non-linear fluorescence 
phenomenon, only tissues at the focal point of the objective are excited and hence the 
technique is inherently confocal, i.e., the only two-photon events that can occur in the tissue 
will be at the focal point of the objective and therefore no confocal pinhole is required to 
remove out-of-focus blur. Similarly, second harmonic generation (SHG) occurs only at the 
focal point of the objective in tissues that have a non-centrosymmetric crystalline structure, 
such as collagen, to produce a strong SHG signal at exactly half the wavelength of pump laser 
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energy by the tissue compared to single-photon excitation if the fundamental wavelength is 
off the resonance wavelength of cellular constituents, and hence, there is negligible thermal or 
phototoxic damage [15]. As both SHG and MPFM utilize pulsed infra-red light this allows 
deep imaging into live tissues (400–1000 µm depending tissue turbidity, pigmentation and 
wavelength) with less scattering of light [15,22,23]. Importantly, the SHG signal is generated 
without the need to stain the tissue in any way, and so this technique lends itself well to be 
used as a non-invasive imaging tool [24,25]. Using second harmonic confocal microscopy we 
have demonstrated that the borders of malignant skin cancers can be easily identified in 
unstained human biopsy skin sections that correlate well with clinical diagnosis of MM. 
We propose that by using SHG imaging the diagnostic process currently used and surgical 
planning can be dramatically enhanced by accurately delineating the borders of invading 
cancer cells at the patient’s first presentation. This could significantly reduce the time taken 
for diagnosis and alleviate the patient of repeated operations and possibly decrease mortality 
rates. 
2. Materials and methods 
Sections from human MM biopsies were acquired from the University of Szeged, Hungary 
with full ethical approval from the host institute and patient consent. Tissue devitalization 
protocols were standardized for all patients and no samples showed any signs of necrosis prior 
to excision. Histological preparation of the tissue was identical for all samples. Five samples 
were diagnosed as superficial spreading MM, one nodular MM and two lentigo mailgnia MM. 
Three samples were from female patients and five from males with an age range of 58–75 
years. Breslow thickness assessments ranged from 0.304 to 1.672 mm and post-MM excision 
survival was 30–84 months. 
Multiple adjacent fields of unstained human melanoma skin sections (4µm) (n = 8 
patients) were imaged using SHG imaging to reveal fibrillar collagen distribution (principally 
Type I and III), followed by single-photon transmission (bright field) imaging. A detailed 
description of the experimental setup is described in [19]. Image acquisition was performed 
on a Leica SP2 AOBS confocal multi-photon laser scanning microscope coupled to a Leica 
DMRE upright microscope (Leica, Milton Keynes, UK), equipped with a pulsed, mode locked 
femtosecond (fs) Ti:sapphire Tsunami laser synchronously pumped by a Millenia VII 
(Spectra-Physics, Mountain View CA), diode pumped solid state frequency doubled laser 
capable of delivering up to 8.5W pumping power at 532nm. 
All SHG image acquisition was performed at 880nm, which has previously been found to 
be the optimum wavelength for collagen types I and III [19]. The pulse width of the Tsunami 
was 80 fs with a pulse repetition rate of 80 Mhz. Laser power output at the microscope 
objective was recorded with a coherent power meter and calibrated for all samples to deliver 
peak power of 0.4 × 10
8 Wcm
2 and was consistently maintained below the damage threshold 
of the samples, which for collagen in sections was found to be 1.5 × 10
8 Wcm
2 [19]. An IST 
laser spectrum analyzer coupled to a Tektronix TDS 210 oscilloscope was used to tune the 
laser to the desired wavelength. An electro-optical modulator (EOM) (Linos LIV20) received 
the laser output before delivery to the confocal microscope through a series of optical mirrors. 
The EOM allowed the laser intensity at the objective to be controlled and optimized. EOM 
was set at 90% to circularly polarize the pump laser beam, so as to ensure the incident beam 
laser remained consistent across all specimens. Thus the potential effects of sample 
polarization versus fundamental pump beam polarization were minimized. 
In order to image the complete section we used a motorized stage (Mietzhouser, GmbH), 
controlled by the Leica software to perform automated montages from multiple fields 
consisting of up to 42 x 19 fields with up to 10 z-sections of 1µm thickness. Samples were 
imaged with a 20x, 0.7NA dry objective and 2x zoom producing an image measuring 375 by 
375 µm at 512 by 512 pixel resolution. The SHG signal in the backscattered geometry was 
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Leica microscope incorporates a programmable, prismatic beam splitter, which is capable of 
single and multi-chromatic beam splitting. The backscattered photons are subsequently 
focused through the objective lens with an estimated beam diameter of 0.24 µm (λp = 880 nm) 
and delivered through the prismatic beam splitter, programmed to collect light at 435-445nm, 
before passing it on to the photomultiplier tube (PMT). This calculation is based on the Guoy 
phase shift and its relationship to the NA of the objective lens, the fundamental wavelength 
and refractive index of the sample [26]. Thus the beam diameter = 0.32λ / 2NA. The 
coherent SHG signal formed in the transmission geometry was detected by the transmission 
detector via the microscope condenser with 445 nm df 30nm band pass filter inserted in the 
light path (Chroma Inc. UK). In addition, a non-confocal, bright-field image was acquired 
(sequentially to the SHG image) using single photon excitation at 488nm, which was collected 
in the transmission PMT. This image served as a reference image to overlay the H&E or 
Melan-A with the SHG images during the assessment stage. At the end of image acquisition 
the automatic montage software produced a final compilation image of the all z-projected 
fields. 
Sister-sections were then imunohistochemically stained for the melanoma marker, Melan-
A, and imaged using conventional light microscopy, then overlaid on the SHG images for 
comparison. The extent of invasion and limits of the borders between the two imaging 
techniques (H&E and or Melan-A) was assessed and marked by two independent 
histopathologists. The lateral boarders of cancer invasion were marked on the SHG images by 
an independent researcher, blinded to the histopathologists assessments, then checked for the 
degree of correlation between the SHG and H&E/Melan-A findings, using Mann-Whitney U-
Test and Kendall-Rank Correlation Analysis. The criteria used for the independent evaluation 
of the MM borders of the SHG images were that one could clearly discriminate undisrupted 
collagen fiber bundles at the dermal-epidermal junction, adjacent to the MM lesion. 
Collagen fiber density was quantified from seven regions using ImageJ image analysis 
software (Freeware, rsbweb.nih.gov) to calculate the percentage area of collagen fibers for 
that region. The images were segmented using an adaptive threshold algorithm with a fixed 
kernel size and offset for all samples. Data was expressed as Area %, calculated using area of 
collagen fibers/ area of measuring frame x 100. Generally SHG produces very high contrast 
images with very low or no background and since pump laser beam polarization was circular, 
segmentation based on threshold values proved to be a robust method. The regions quantified 
are highlighted in Fig. 2A and were an area of non-lesion skin under the dermal-epidermal 
junction (labeled A), the lateral melanoma border under dermal-epidermal junction (labeled 
B), an area under the middle part of the lesion and under the dermal-epidermal junction 
(labeled C), the areas labeled D, E, F, are all below C but one field vertically deeper to each 
other, and the area of dermis at the same depth as F but away from the lesion (labeled G in 
Fig. 2A). 
Fresh pieces of whole rat and human skin were cleared of subcutaneous fat and connective 
tissue, and hair in the case of the rat samples, and mounted onto glass slides in PBS buffer. 
Human skin samples were collected from The Royal London Hospital Trust, department of 
surgery with full patient consent and ethical approval, and imaged within four hours. One 
sample was from 22 year old, breast reduction patient, and the other three samples were breast 
reconstructions from age rages of 30–45 years. Two samples appeared heavily pigmented 
whilst the other two appeared very lightly pigmented. SHG image acquisition was performed 
in both backscattered and forward propagated (transmission) geometries from the epithelial 
surface and imaged at full depth (deep into the dermis) in order to demonstrate that the 
technique is transferable to intact live skin. A Leica 20x 0.7 NA, long working distance 
objective, was used for image acquisition. A single field of 512 x 512 pixels (750 x 750 µm or 
430 x 430 µm) at zoom 1.0 or 1.7 at 800 Hz with 2.5µm z-step, an imaging average of 2 
frames was acquired for both rat and human ex vivo samples. Typical imaging times for ex 
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imaging times did not exceed 3 min. 3D-images were generated with Imaris visualization 
software (Bitplane Scientific Software. Zurich, Switzerland). 
3. Results 
Three images were obtained for each unstained melanoma section; an SHG image in the 
forward propagated (Fig. 1A) and backscattered geometries (Fig. 1B), followed by a bright 
field image (Fig. 1C). Bright field and SHG images superimposed gave an image of collagen 
distribution within the bright field background for each section (Fig. 1D). 
The SHG collagen signal showed a rapid transition at the two lateral melanoma borders, 
from very low or no SHG signal to that of normal collagen distribution found in non-lesion 
areas of skin. Medial to the melanoma borders there was a dramatic reduction in collagen 
SHG signal making the identification of the lateral boarders of cancer invasion unambiguous 
(Fig. 1D, 2A, 3C and 4B). 
 
Fig. 1. Montage of SHG images in the forward propagated (A), backscattered geometry (B), 
and bright field image (C). Superimposed images of bright-field and SHG images indicate 
collagen distribution within each section (D). Scale bar = 1mm 
Quantification of collagen fiber density from different regions around the MM lesion 
showed varying degrees of fiber density, expressed as Area %, ranging from 0.8% in the 
region labeled (C) (Fig. 2A) in the middle of the MM lesion, to 38% per unit area, in non-
lesion area of skin labeled (A and G) (Figs. 2A and B). In regions labeled (D, E and F) there 
was a gradual increase of collagen fiber density from 9.1% to 19.88% to 33.2%, respectively 
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towards a more ‘normal’ collagen fiber density. Each microscopic field (one tile in the 
montage) is equivalent to 375µm; therefore the collagen fiber density goes from almost zero 
in region C to 33.2% in region F, a distance of 1500µm (Figs. 2A-B). In the non-diseased 
areas of all skin sections we found a normal distribution of collagen up to the dermo-
epidermal junction. Linear regression of collagen fiber density from region C (minimum SHG 
signal) to region G (maximum SHG signal in non-diseased area) showed an R
2 value of 
0.9849 suggesting that collagen fiber density is a good biomarker for malignancy (Fig. 2B). 
 
Fig. 2. (A) Enlarged view of Fig. 1D showing regions from which collagen fiber density was 
quantified. A = Area of normal skin under dermal-epidermal junction, B = Lateral melanoma 
border under dermal-epidermal junction, C = Area under the middle part of the lesion and 
under dermal-epidermal junction, areas D, E, F, are all below C but one field vertically deeper 
to each other, area G is at the same depth as F but away from the lesion (A). (B) Graph of 
collagen fiber density (Area %, ± SE) of the individual regions of A (n = 5-8). On some 
samples not all regions could be quantified because the biopsies were cut to shallow, i.e., not 
enough dermis depth present, therefore the deeper regions were absent and hence there is no 
data and the n-number vary. Note regression line illustrating a linear correlation of collagen 
fiber density (R
2 = 0.9849) from region C (mid-point of MM lesion) to region G (deep area of 
non-lesion skin). Scale bar = 1mm 
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Fig. 3. Cross-reference control comparison of melanoma borders obtained from H&E (A) and 
Melan-A stained sister sections (B) and comparison with SHG (C) showed a high degree of 
correlation (p<0.0012). Vertical lines (black lines in A & B; white lines in C) represent lateral 
borders of MM as identified by two independent histopathologists (A and B) and independent 
researcher (C). Red box (B-C) represents the areas shown at high power in Figs. 4A and 4B, 
respectively. Scale bar = 1mm 
Assessment of the lateral melanoma borders derived from SHG images versus H&E 
images (Fig. 3A) by the histopathologist were found, on direct observation, to co-localize in 
almost exactly the same positions (Fig. 3C). Cross-reference control comparison showed that 
melanoma borders obtained from H&E and Melan-A stained sister sections were also well co-
localized (Figs. 3A and B, Figs. 4A and B). 
Non-parametric statistical analysis using Mann-Whitney U-Test revealed no significant 
difference between the lateral melanoma borders as determined by an independent 
histopathologist using H&E sections and those assessed by an independent scientist using the 
SHG images of the corresponding unstained sister section (Fig. 5A). p-values for the right 
lateral border comparison was p = 0.9491 representing a mean difference of 0.85 mm ± 0.18 
mm (SE) (n = 7) and for the left border p = 0.9164 representing a mean difference of 0.55 mm 
± 0.13 mm (SE) (n = 8), respectively (Fig. 5B). The total p-value for both sides was p = 
0.9339. Kendall-Rank Correlation Analysis revealed a highly significant correlation between 
the lateral melanoma borders derived from histopathologists assessment and those from SHG 
images. p-value for the right lateral border comparison was p = 0.0069 (n = 7) and for the left  
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Fig. 4. High magnification images of Fig. 3. Melan-A staining (A), SHG/brightfield image (B), 
corresponding to left hand border (red boxes) in Figs. 3B and 3C, respectively. Note that the 
SHG signal starts to reappear at the dermo-epidermal junction at the point where MM lesion is 
absent. Scale bar = 1mm 
side p = 0.0260. (n = 8) The tied p-values for the right and left sides were p = 0.0056 and p = 
0.0260, respectively. The total p-value for both sides correlation analysis was p = 0.0012 (Fig. 
5B). 
SHG imaging of whole, ex vivo rat (Fig. 6A) and human skin (Fig. 6 B) samples yielded 
detailed images of collagen morphology through the entire thickness when imaged from the 
epidermis, in both backscattered and transmission geometries. In the case of rat skin, SHG  
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Fig. 5. Measured distance from center of each MM sample to left and right borders of lesion for 
SHG (dotted infill = left border, horizontal line infill = right border) stained section and H&E 
(diagonal hatch infill = left border, checker hatch infill = right border) imaged sister section 
(A). Mean difference of distance for left and right MM borders of H&E versus SHG images 
(B). Statistical analysis shows no significant difference between the two methods with total p-
value for both sides p = 0.9339, whilst Kendall-Rank Correlation Analysis Showed a total p-
value for both sides p = 0.0012. 
transmission images were detected through the whole thickness of the skin, although only the 
upper 150 µm is shown in (Fig. 6A). The blue channel is the two-photon auto fluorescence 
image of the upper epidermis, whilst the red and green channels are the transmitted and back-
scattered SHG signals, respectively. In the lightly pigmented human skin samples, we were 
able to image through the whole thickness of epidermis and dermis to depths of approximately 
300µm in the back-scattered geometry (green signal) and over 1000µm in the transmission 
geometry (red signal) (Fig. 6B). The heavily pigmented human samples could not be imaged 
from the epidermal surface, presumably because of the absorption of the 880nm wavelength 
light by melanin. However, if the samples were imaged from the dermal surface, clear SHG 
images of collagen were detected in both forward and back-scattered geometries (images not 
shown). Scale bars = 50 µm for each orthogonal plane. 
These data support our hypothesis in that there are no significant differences between the 
two methods of identifying the borders of the MM lesions. Furthermore, it also emphases the 
fact that the extent of MM lesion can be asymmetrical and hence using Breslow thickness 
alone to empirically define a radius from the center of the MM lesion can in many cases be 
insufficient. This effect can be compounded in cases where there is very irregular shaped, 
MM lesions and would lead to more than one attempt to surgically remove the tumor. 
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Fig. 6. SHG imaging of normal, ex vivo, live rat skin (A) and human skin sample (B) showing 
collagen morphology throughout the entire thickness when imaged from the epidermis, in the 
transmission (red) and back-scattered (green) geometry. Rat skin, SHG transmission images 
(red) and back-scattered SHG signal (green) were detected through the whole thickness of the 
skin (A). The blue channel is the two-photon auto fluorescence image of the upper epidermis, 
whilst the yellow represents the colocalization of the red and green channels. In lightly 
pigmented human skin samples, we were able to image through the whole thickness of 
epidermis and dermis to depths of approximately 300µm in the back-scattered geometry (green 
signal) and over 1000µm in the transmission geometry (red signal) (B). Scale bars = 50 µm for 
each orthogonal plane. 
4. Discussion 
We have demonstrated that SHG microscopy is a rapid and reliable method for the clinical 
management of MM by defining the borders of the lesions and the extent of dermal invasion 
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accurately define the lateral borders in histological sections of MM biopsies, which correlate 
significantly with the current gold standard assessments (H&E and Mealn A). This study 
provides initial evidence that collagen density in and around the suspected MM lesion may 
possibly be used as a biomarker for skin cancer diagnostics; further studies are in progress to 
confirm if collagen density and or architecture can differentiate a MM from a squamous cell 
or basal cell carcinoma as well as other skin tumors. Therefore, the in vivo applicability and 
identification of skin tumors using SHG microscopy is at present independent of lesion type 
so clear identification/confirmation is still required. The scant data in the literature about 
collagen fiber density around MM and NMSC lesions’ warrants more detailed studies but 
until then current diagnostic practices will still require immunophenotyping. In the diseased 
areas we observed a gradual decline in collagen density. This was most dramatic in the areas 
directly under the melanoma, which showed the weakest SHG signal; in most cases there was 
a complete absence of SHG signal due to the destruction of collagen by MMP’s produced by 
the malignant melanocytes. In the MM lesion areas the collagen morphology was greatly 
affected and was present in very short, thin ‘wispy’ fibers. The SHG signal then intensified 
with increasing depth below the lesion, until the collagen took on a more normal appearance. 
Furthermore, we have demonstrated that SHG imaging can detect collagen in freshly excised 
human and rat skin samples in both the back-scattered and transmission geometries; up to 300 
µm and 1mm, respectively. 
SHG imaging has been used to detect collagen non-invasively in many tissues including 
human skin [27,28]. It is a non-absorptive, non-linear, two-photon optical effect that can 
detect non-centrosymmetric crystalline structures such as collagen type I and III in unstained, 
live and fixed tissues [27,28]. It typically employs infrared or longer wavelength pulsed 
lasers, enabling good depth penetration and very little or no phototoxicity to tissues. 
Furthermore, the non-absorptive nature of the technique results in conservation of energy and 
therefore little or no heat is dissipated into non-pigmented tissue from the laser source, which 
would otherwise damage or even destroy live tissues. 
Until social attitudes to skin cancer prevention are changed, early detection and treatment 
is the key to reducing mortality rates. Therefore the major challenge for skin cancer 
diagnostics is the early detection of non-metastasized malignant lesions and to reliably 
differentiate these from the less life threatening malignant cancers such as SCC, BCC and 
benign nevi BN, at the time the patient presents to the clinician. The most significant risk to 
life is MM and early detection and excision is crucial if the chances of survival are to be 
maximized [29,30]. SCC and BCC represent a much lower risk to life expectancy and are 
highly treatable if the correct diagnosis is made early on in the disease [29,30]. BN present 
little or no risk to patient survival; however, accurate diagnosis is required, as these can often 
resemble MM lesions. In addition, an apparently BN may become dysplastic and progress to a 
MM. 
One of the key features of all skin cancers is the remodeling of extracellular matrix by 
MMP’s, principally collagen type I and III, which is clearly seen to be disrupted along the 
borders of the invading cancer cells [31] and missing in the diseased tissue itself. However, 
current diagnostic procedures do not include assessment of collagen density/architecture as a 
parameter, even though this is a key event in skin cancer progression and can potentially be 
used as a biomarker. We propose that collagen architecture, and its presence or absence can be 
used as, 1) a reliable marker of MM invasion through tissues, and 2) that it can be used to 
accurately define melanoma invasion borders. 
A number of non-invasive and experimental imaging techniques are currently being used 
in dermatology clinics throughout the world including the Dermatascope [32,33] and single- 
or two-photon epifluorescence confocal microscope based systems [34]. However, anecdotal 
reports and clinical interpretations of these techniques have been varied, with a tendency 
towards over diagnosing non-malignant conditions such as SCC and BCC putting them 
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psychological stress for patents, believing that they have a MM, and ultimately, leads to 
increased costs to the Health Services. More importantly however, is the reliability and 
accuracy in misdiagnosis of a MM where current, non-histological methods, have a maximum 
of 87% specificity rate compared to CLSM of 98% [34]. 
The data from this study clearly shows that there can be very significant differences in the 
distance from the center of the tumor to the left and right hand borders of irregular shaped 
MM lesions; In Fig. 5A, sample numbers 3 and 6, show an approximately 50% differences in 
left- and right-hand borders, illustrating that the tumors in these samples were asymmetric. If 
this asymmetry were significant then clinical management of MM based on Breslow thickness 
measurements would not be sufficient in determining how much tissue to excise from the 
center of the tumor so as to encompass all the borders. The current practice can lead to 
multiple excision biopsies being performed, and in some cases, putting the patient at increased 
risk of tumor metastasis. Therefore, present-day methods for skin cancer diagnostics are 
complicated by the lack of a reliable non-invasive assessment technique that could eliminate 
the excision biopsy stage of the assessment if it is found to be non-malignant. A recent study 
suggests that collagen SHG signature is a promising marker for MM diagnosis [35] and this 
study supports that notion. 
Any future diagnostic instrument will depend on the ability to image through the surface 
of the skin and thus the back-scattered signal is more important in this respect. Selecting the 
appropriate wavelength to ensure adequate depth penetration and to overcome absorption of 
the light by melanin will be crucial to the success of any such instrument. We found that at 
880nm we could not detect an SHG signal from heavily pigmented human skin samples from 
the epidermal surface, but was able to when imaged from the dermal surface. This result 
emphasizes the need to fully assess the tissue wavelength absorbance characteristics so that 
SHG imaging can be performed in pigmented as well as non-pigmented samples. Other 
groups have shown, with custom built microscopes that longer infra-red wavelengths (1200 
1300 nm) can overcome the absorbance of shorter infra-red wavelength (880 nm) we have 
used in this study [28]. However, in lightly pigmented skin the areas immediately outside of a 
suspected cancerous lesion would still be penetrable by 880nm light, although longer 
wavelengths would be more appropriate. Our research is aimed at developing a low 
resolution, fiber optic, handheld device that can give rapid and reliable assessment of collagen 
presence/absence outlining the MM lesion, in the first instance, and then a high resolution 
lens-based system for differentiating between, MM, SCC, BCC and BN based on collagen 
architecture and density. It is important to note that the low resolution system needs only to 
penetrate the skin to just below the dermal-epidermal border as this will detect the presence 
(presumptive normal, non-diseased tissue) or absence (presumptive MM lesion) of the 
collagen SHG signal The clear and unequivocal data from this study provide good evidence 
that SHG imaging can be a viable alternative to the existing diagnostic procedures. 
5. Conclusions 
In conclusion, this study provides good evidence that SHG imaging has the potential to 
improve on the current excision biopsy stages of MM diagnosis with a single assessment at 
first presentation of the patient. This can potentially shorten the diagnostic process and by 
demarcating the boundaries accurately ensure that the entire MM is removed first time thereby 
saving lives. 
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